My New York City practice has been a refractive-only practice for more than 25 years, offering the full range of FDA-approved ...

The Conversation reports cataract surgery is safe and common, with over 90% achieving 20/20 vision, but patients need to ...

For most people, a cataract diagnosis once meant accepting blurry, faded vision as an inevitable part of aging. But at Frantz ...

I was teased as “four-eyes”, had the frames ripped from my face, sometimes forced to fight – half-blind – to get them back.

Vision Care delivered Q4 sales of $1.2 billion, up 7% year on year, as the segment benefited from innovation and pricing actions. Contact Lens revenue increased 4% to $683 million despite tough ...

Eye Cancer, Known Medically as Retinoblastoma, Is a Rare Eye Condition Retinoblastoma is a rare eye condition that primarily ...

Moby Strategic Performance and Market Positioning. Management attributed the 19% year-over-year revenue decline in Q4 to a ...

The TECNIS PureSee IOL addresses both cataract-related vision loss and presbyopia, which affects near vision as eyes age.

Johnson & Johnson (JNJ) wins FDA approval for Tecnis PureSee intraocular lens ((IOL)), giving eye surgeons a new lens option ...

Johnson & Johnson (NYSE: JNJ) announced that it received FDA approval for its Tecnis PureSee intraocular lens (IOL) for ...

Enhancement coverage applies within 24 months of the original procedure for refractive and premium lens pathways. Beyond this ...

The FDA approved the Tecnis PureSee IOL, an extended depth of focus IOL for cataract surgery, according to a press release ...